Clinical trials
Enrolling by invitation Lung Diseases, Interstitial trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Icahn School of Medicine at Mount Sinai | 1 |
| Paragonix Technologies | 1 |
| State University of New York at Buffalo | 1 |
| United Therapeutics | 1 |
| University of Virginia | 1 |
| VA Office of Research and Development | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 6 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Idiopathic Pulmonary Fibrosis | 2 |
| Alveolitis, Extrinsic Allergic | 1 |
| Connective Tissue Diseases | 1 |
| Cystic Fibrosis | 1 |
| Emphysema | 1 |
| Heart Failure | 1 |
| Hypoxia | 1 |
| Idiopathic Interstitial Pneumonias | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.